Live Webinar on Dec 4! Cut Through the AI Noise: A Framework for Canadian Clinicians. Register now
[searchwp_form id="1"]

Loading results ...

GLP-1 Usage Table

mai 21, 2024

GLP-1 Usage Table

The medical conditions for which each GLP-1 medication is indicated

Medication

Approved Uses

Dosing Frequency

Initial Dose

Maintenance Dose

Benefits

Ozempic

Type 2 Diabetes

Once weekly

0.25 mg

Up to 1 mg

Reduces A1C, supports weight loss

Wegovy

Obesity (BMI ≥30, or BMI ≥27 with at least one weight-related condition)

Once weekly

0.25 mg

Up to 2.4 mg

Significant weight loss

Victoza

Type 2 Diabetes, to reduce the risk of major cardiovascular events

Daily

0.6 mg

Up to 1.8 mg

Lowers cardiovascular risk in addition to managing diabetes

Saxenda

Obesity (BMI ≥30, or BMI ≥27 with at least one weight-related condition)

Daily

0.6 mg

Up to 3.0 mg

Promotes weight loss

Mounjaro

Type 2 Diabetes, Obesity (BMI ≥30, or BMI ≥27 with weight-related comorbidities)

Weekly

2.5 mg

Up to 15 mg

Lowers blood sugar and body weight

Rybelsus

Type 2 Diabetes

Daily

3 mg

Up to 14 mg

Convenient for those who prefer pills

Zepbound

Type 2 Diabetes, Obesity (BMI ≥30, or BMI ≥27 with weight-related comorbidities)

Weekly

2.5 mg

5-15 mg

Substantial weight loss over longer periods

postcall_newsletter_header_with_border

Latest Articles

Share this Article

Keep Reading

Explore related articles.